PR Newswire
MINNEAPOLIS, Feb. 13, 2017
MINNEAPOLIS, Feb. 13, 2017 /PRNewswire/ -- Bio-Techne
Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, Chief Executive Officer, will
present at the Leerink Partners 6th Annual Global Healthcare conference on Thursday, February
16, 2017, at 11:30 a.m. EST. The conference will be held at The Lotte New York Palace in
New York City.
Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high quality purified proteins––notably
cytokines and growth factors, antibodies, immunoassays, as well as biologically active small molecule compounds --- which are
sold to biomedical researchers and clinical research laboratories; these operations constitute the core Biotech Division,
headquartered in Minneapolis, Minnesota. The Protein Platform Division manufactures
innovative protein analysis tools under the ProteinSimple brand name that greatly automate western blotting and immunoassay
practices. The Diagnostics Division manufactures FDA-regulated controls, calibrators, blood gas and clinical chemistry controls
for OEM customer and clinical customers. Bio-Techne products assist scientific investigations into biological processes and the
nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests
and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $499
million in net sales in fiscal 2016 and has approximately 1,700 employees worldwide. For more information on Bio-Techne
and its brands, please visit www.bio-techne.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-leerink-partners-6th-annual-global-healthcare-conference-300405841.html
SOURCE Bio-Techne Corporation
